Similar Posts
2027 Dr. Francis S. Collins Scholar Award Recipient, Maximilian Horlbeck, MD, PhD
The American Pediatric Society (APS) and Society for Pediatric Research® (SPR) are pleased to announce that Maximilian Horlbeck, MD, PhD, has been selected as the 2027 Dr. Francis S. Collins Scholar Award recipient.
2026-2027 APS SPR Journeys Program Opening Plenary
The American Pediatric Society (APS) and the Society for Pediatric Research® (SPR) are pleased to announce the Journeys & Frontiers in Pediatric Research Opening Plenary, taking place on November 13 from 10-11 am CT, featuring keynote speaker Sallie Permar, MD, PhD.
The Society for Pediatric Research announces new members for 2025
HOUSTON, November 19, 2024 – The Society for Pediatric Research (SPR) is pleased to announce 126 new members. SPR encourages and supports pediatric research endeavors by cultivating a diverse network of child health researchers through collaboration, community, mentorship, and advocacy. Collaboration among SPR members creates meaningful progress for the future of children’s health. Active members are…
Community Vaccine Education in Practice: Ann Chahroudi, MD, PhD, at the Atlanta Science Festival
At the 2026 Atlanta Science Festival, SPR Strategy and Operations Officer, Ann Chahroudi, MD, PhD, joined volunteers from the Emory Immunology Graduate Group (IgG), the Emory Vaccine Center, and the Emory National Primate Research Center to engage children and families in conversations about vaccines. Their booth, “How do vaccines protect us?” made vaccine science approachable, memorable, and safe to ask about.
Get Involved in SPR National Leadership Service Opportunities
The Society for Pediatric Research® (SPR) is excited to open its call for National Leadership Service Opportunities. This is your chance to bring your expertise to the table, help shape the future of pediatric research, and advance the Society’s mission.
Interrogation of Disrupted Vascular Development Signals in Early Preterm Birth
Faizah Bhatti’s, MD, research focuses on understanding how inflammation increases the risk of abnormal blood vessel development in preterm infants, and ultimately, to find ways to prevent complications related to vascular dysgenesis.
